83
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Treatment of Allergic Rhinitis and Asthma in Primary Care: Dispensations Do Not Align with Prescriptions

ORCID Icon, , , , & ORCID Icon
Pages 1721-1729 | Received 31 May 2022, Accepted 20 Nov 2022, Published online: 25 Nov 2022

References

  • Martinez FD, Vercelli D. Asthma. Lancet. 2013;382(9901):1360–1372. doi:10.1016/S0140-6736(13)61536-6
  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: www.ginasthma.org. Accessed November 22, 2022.
  • Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi:10.1016/j.jaci.2017.03.050
  • Becher H, Kostev K, Schroder-Bernhardi D. Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther. 2009;47(10):617–626. doi:10.5414/CPP47617
  • Tuppin P, Rudant J, Constantinou P, et al. Value of a national administrative database to guide public decisions, From the systeme national d’information interregimes de l’Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(Suppl 4):S149–S67. doi:10.1016/j.respe.2017.05.004
  • Belhassen M, Nolin M, Nibber A, Ginoux M, Devouassoux G, Van Ganse E. Changes in persistent asthma care and outcomes from 2006 to 2016 in France. J Allergy Clin Immunol Pract. 2019;7(6):1858–1867. doi:10.1016/j.jaip.2019.02.025
  • Bosnic-Anticevich S, Kritikos V, Carter V, et al. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia. J Asthma. 2018;55(6):684–694. doi:10.1080/02770903.2017.1353611
  • Belhassen M, Demoly P, Bloch-Morot E, et al. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017;72(6):948–958. doi:10.1111/all.13098
  • Laforest L, Licaj I, Devouassoux G, et al. Prescribed therapy for asthma, therapeutic ratios and outcomes. BMC Fam Pract. 2015;16:49. doi:10.1186/s12875-015-0265-2
  • Laforest L, Licaj I, Devouassoux G, Chatte G, Martin J, Van Ganse E. Asthma drug ratios and exacerbations, claims data from universal health coverage systems. Eur Respir J. 2014;43(5):1378–1386. doi:10.1183/09031936.00100113
  • Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control, a 3-year analysis of patient claims. J Allergy Clin Immunol. 2005;115(5):935–939. doi:10.1016/j.jaci.2005.01.054
  • Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43(3):413–422. doi:10.1345/aph.1L496
  • Yegit OO, Demir S, Unal D, et al. Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic. Allergy. 2021;77(1):197–206.
  • Laforest L, El Hasnaoui A, Pribil C, et al. Asthma patients’ self-reported behaviours toward inhaled corticosteroids. Respir Med. 2009;103(9):1366–1375. doi:10.1016/j.rmed.2009.03.010
  • Mazalovic K, Jacoud F, Dima AL, et al. Asthma exacerbations and socio-economic status in French adults with persistent asthma: A prospective cohort study. J Asthma. 2018;55(10):1043–1051.
  • Belhassen M, Langlois C, Laforest L, et al. Level of Asthma Controller Therapy Before Admission to the Hospital. J Allergy Clin Immunol Pract. 2016;4(5):877–883. doi:10.1016/j.jaip.2016.06.012
  • Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative For Asthma (GINA) strategy 2021 - executive summary and rationale for key changes. Am J Respir Crit Care Med. 2021;27(1):14–35.
  • Van Ganse E, Texier N, Dima AL, et al. Effects of short- and long-acting beta-agonists on asthma exacerbations, a prospective cohort. Ann Allergy Asthma Immunol. 2020;124(3):254–260. doi:10.1016/j.anai.2019.12.012
  • Belhassen M, Nibber A, Van Ganse E, et al. Inappropriate asthma therapy-a tale of two countries, a parallel population-based cohort study. NPJ Prim Care Respir Med. 2016;26:16076. doi:10.1038/npjpcrm.2016.76
  • Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Intern Med. 1994;154(12):1349–1352. doi:10.1001/archinte.1994.00420120066007
  • Juel-Berg N, Darling P, Bolvig J, et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis, A systematic review and meta-analysis. Am J Rhinol Allergy. 2017;31(1):19–28. doi:10.2500/ajra.2016.30.4397
  • Dahlen E, Ekberg S, Lundholm C, et al. Sibship and dispensing patterns of asthma medication in young children-a population-based study. Pharmacoepidemiol Drug Saf. 2019;28(8):1109–1116. doi:10.1002/pds.4802
  • Van Ganse E, Laforest L, Pietri G, et al. Persistent asthma, disease control, resource utilisation and direct costs. Eur Respir J. 2002;20(2):260–267. doi:10.1183/09031936.02.02542001
  • Baptist AP, Hao W, Song PX, Carpenter L, Steinberg J, Cardozo LJ. A behavioral intervention can decrease asthma exacerbations in older adults. Ann Allergy Asthma Immunol. 2020;124(3):248–53 e3. doi:10.1016/j.anai.2019.12.015
  • de Bruin M, Dima AL, Texier N, van Ganse E. Explaining the amount and consistency of medical care and self-management support in asthma, a survey of primary care providers in France and the United Kingdom. J Allergy Clin Immunol Pract. 2018;6(6):1916–25 e7. doi:10.1016/j.jaip.2018.04.039
  • Hodkinson A, Bower P, Grigoroglou C, et al. Self-management interventions to reduce healthcare use and improve quality of life among patients with asthma, systematic review and network meta-analysis. BMJ. 2020;370:m2521. doi:10.1136/bmj.m2521